VHL and pancreatic neuroendocrine tumor: Notably, given the high objective response rates observed in VHL patients with pancreatic NETs, and the known angiogenic signaling implicated in sporadic NETs, a cohort of patients with sporadic advanced pancreatic NETs was also included.